The award recognizes investigations that have “significantly advanced the fields of cardiovascular biology or cardiovascular health within the past five years.”

The team's findings could lead to new strategies which improve efficacy of these treatments and expand lifesaving options for cancer patients.

She hopes others will join her in participating in or contributing to Team Vanderbilt’s efforts at this year’s Susan G. Komen More Than Pink Walk, on Oct. 3.

Accredited as a Rare Disease Pharmacy Center of Excellence, VSP manages specialty medications and offers high-touch pharmacy services for patients with complex and often chronic, rare conditions.

Vanderbilt's clinical, academic, and health-system perspective was applied to a central question: How can promising technologies be translated into better outcomes for patients and communities?

Young man’s dream of becoming a cardiologist bolstered by one of Vanderbilt’s best

Vanderbilt’s Master of Public Health grads are the problem solvers the world needs